Skip to main content

Organigram Global Inc.

OGI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001620737

No open-market purchases or sales by Organigram Global Inc. insiders were filed in the last 90 days; 69 institutions reported holding it in 13F filings for Q2 2026, worth $7.87M in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Organigram Global Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of OGI: Q2 2025 compared with Q3 2025
MeasureQ2 2025Of which not filed for Q3 2025Q3 2025Change
Holders75167−7
Shares7.41M998.91M+1.50M (+20.2%)
Value$10.0M$134$18.1M+$8.09M (+80.8%)

1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (9)

Institutions that held Organigram Global Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to OGI in Q3 2025
InstitutionSharesValue% of portfolio
Two Sigma Investments, LP446,692$906.8K0.00%
Jane Street Group, LLC220,929$448.5K0.00%
CI Private Wealth, LLC25,125$51.0K0.00%
Security National Bank1,050$2.13K0.00%
Advisory Services Network, LLC986$2.00K0.00%
MTM Investment Management, LLC333$6760.00%
Larson Financial Group LLC125$2540.00%
First Horizon Corp99$2010.00%
Steigerwald, Gordon & Koch Inc.1$20.00%

Sold out (16)

Institutions that held Organigram Global Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Not filed for Q3 2025 yet (1)

Institutions that held Organigram Global Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OGI in Q2 2025 that haven't filed for Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
First Horizon Advisors, Inc.99$134